Program A

BEHAVIORAL3 trials

Sponsors

University of California, Los Angeles, University Hospital, Toulouse, University of Rochester

Conditions

Chronic Kidney DiseasesHearing LossSleep Initiation and Maintenance Disorders

Unknown Phase

Sleep Without Insomnia or The Use of Chronic Hypnotics

CompletedNCT03687086

University of California, Los AngelesSleep Initiation and Maintenance Disorders

Start: 2018-12-11End: 2023-11-27Updated: 2026-04-07

Optimization of Hearing Performance in the Subject Implanted

University Hospital, ToulouseHearing Loss

Start: 2023-05-18End: 2025-01-18Target: 50Updated: 2023-08-24

Chronic Kidney Disease-Education (CKD-EDU)

RecruitingNCT06410144

University of RochesterChronic Kidney Diseases

Start: 2025-02-27End: 2028-12-31Target: 326Updated: 2026-05-05

Related Papers

Sleep aid usage following benzodiazepine receptor agonist tapering and cognitive behavioral therapy for insomnia in middle-aged and older adults.

2026-05-21

0442 Predicting Sleepiness from Verbal Reaction Time During Verbal Cognitive Testing

SLEEP2025-05-01

DOES THE PERCEIVED DOSAGE OF BZRAS DURING TAPERING AFFECT SLEEP QUALITY IN OLDER ADULTS?

Innovation in Aging2024-12-01

Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists

JAMA Internal Medicine2024-10-0713 citations

Sleep characteristics and use of multiple benzodiazepine receptor agonists in older adults

Journal of the American Geriatrics Society2023-08-011 citations